The media is doing its best to ignore the solid new evidence that hydroxychloroquine (HCQ) works. Although they claim to be pro-science, they only report scientific studies that agree with their narrative. Although they claim that black lives matter to them, they purposely keep knowledge about successful treatments away from COVID-19 patients, a disproportionate number of whom are black. Here are some details of the two new studies that almost all of them are ignoring:
- Henry Ford Health System. Last week, the International Journal of Infectious Diseases reported that hydroxychloroquine cuts the death rate in half when it is administered to hospitalized COVID-19 patients soon after they are admitted. The retrospective study of 2,541 patients was conducted by the Henry Ford Health System in Detroit Michigan. Only 13% of the patients who were given HCQ died as compared to 26% who were not given HCQ. HCQ worked whether or not it was given with the antibiotic azithromycin, but it appeared to work slightly better with azithromycin. Key to the study was early treatment with HCQ, with 91% in the HCQ group starting that medication within 48 hours of hospital admission.
- Mount Sinai Hospital. Also last week, Nature Reviews Immunology published the results of the small but ideal type of experiment (a double-blind, randomized clinical trial) conducted by Mount Sinai Hospital in New York which found that 0 of 31 patients in the HCQ group progressed from mild to severe as compared to 4 of 31 patients in the control group.
The media is also ignoring the May 8 study of 932 patients by the New York University Grossman School of Medicine which compared the HCQ/azithromycin treatment with the HCQ/azithromycin/zinc treatment.
(Excerpt) Read more at: